A phase 2B, open-label multicenter study of tebapivat (AG-946), a potent pyruvate kinase activator, in patients Meeting Abstract
| Authors: | Zeidan, A. M.; Sekeres, M. A.; Al-Samkari, H.; Carraway, H. E.; DeZern, A. E.; Mittelman, M.; Little, M.; Beynon, V.; Dai, X.; Sommakia, S.; Despotovic, J. M.; Patel, P.; Dibacco, M.; Fattizzo, B.; Stein, E. M.; Sallman, D.; Kulasekararaj, A. G.; Platzbecker, U.; Fenaux, P. |
| Abstract Title: | A phase 2B, open-label multicenter study of tebapivat (AG-946), a potent pyruvate kinase activator, in patients |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 6708 |
| Language: | English |
| ACCESSION: | WOS:001410849000049 |
| DOI: | 10.1182/blood-2024-203073 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
